Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.
about
Impact of recent innovations in the use of mass cytometry in support of drug developmentIntravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progressionAdvancing biomedical imagingEribulin in Cancer TreatmentMultiscale Framework for Imaging Radiolabeled TherapeuticsReal-time high dynamic range laser scanning microscopyHeterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.Design and Development of Fluorescent Vemurafenib Analogs for In Vivo ImagingNano-palladium is a cellular catalyst for in vivo chemistryAdvances in measuring single-cell pharmacology in vivo.Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.Two-photon Fluorescence Anisotropy Microscopy for Imaging and Direct Measurement of Intracellular Drug Target Engagement.ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines.MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.Anti-Microtubule Drugs.Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents.Cancer nanomedicine: progress, challenges and opportunities.Eribulin in non-small cell lung cancer: challenges and potential strategies.Imaging of anticancer drug action in single cells.Quantitating drug-target engagement in single cells in vitro and in vivo.Engineering and physical sciences in oncology: challenges and opportunities.Two-Photon Intravital Microscopy Animal Preparation Protocol to Study Cellular Dynamics in Pathogenesis.Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging.Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling.Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy.
P2860
Q23909636-68B069C4-949F-4E45-8FA3-03D0C80C926AQ26745311-028DC006-7859-4CCF-AE13-51FE55EBBFE1Q26776383-B996E2BF-06FF-4EFC-BB8F-09C45CD1A13EQ26799328-1396220B-D6F7-4F06-AC3F-4A74AD2D898AQ27301080-D2D552DD-3158-4F4E-A657-1E3093C0CCECQ27322971-431A8E43-CDD1-4F19-B518-7EB9413749EDQ30838654-078CFA5D-F74B-4479-8F17-3EAADBA90EA6Q33588217-2F7EE7B5-B89C-4639-8F2E-3E891A653495Q33903811-00DA85A2-6958-4926-903B-8AC313CEEF15Q36054366-8ED94938-8245-4F77-A054-F3CDED0B7052Q36459188-C701EF6D-B329-491C-BD6E-BF84D29FA5CCQ37098162-80422B1A-D98E-48BD-AEBE-2397BFB20D68Q37688480-7B715821-4CB3-46A2-B250-41D64AA313F4Q38733113-A6728D7B-9A5A-4BDD-85A9-EEED20EAD5EDQ38837821-223ED0D8-D193-4DE8-A2BC-BA0976D4E1AFQ38856246-E5D905FB-5AD1-4EDC-B916-BDDA5D0C2639Q38887857-2FDFC59E-7DDE-4BCC-830A-A78EE2491A03Q39005226-114052B9-799C-4260-9A42-B8B431CB28A9Q39120142-FA0A2933-125A-4B35-8CF7-ECB647E86316Q39392711-B411C04A-7E5F-4CEB-9B87-245B0585E1B0Q42275555-0DBD576F-A93A-459B-96A1-341D573464FBQ47244877-D7E46F7B-F5EB-467E-8FDD-99A64F3BA8E7Q47943783-D0A815D8-14A8-42B8-9D33-8FDEB1585560Q47949142-C3A53EB7-253B-4A35-BA39-A56BAC7D6C40Q52684332-6F2C8436-6D45-4D80-9A3F-048669130FCFQ55688327-EBC288EC-D259-49F0-8915-080967126E0D
P2860
Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@ast
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@en
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@nl
type
label
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@ast
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@en
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@nl
prefLabel
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@ast
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@en
Single-cell pharmacokinetic im ...... icrotubule inhibitor eribulin.
@nl
P2093
P2860
P50
P1476
Single-cell pharmacokinetic im ...... microtubule inhibitor eribulin
@en
P2093
Ashley M Laughney
Katy S Yang
Melissa M Sprachman
Timothy J Mitchison
P2860
P304
P356
10.1126/SCITRANSLMED.3009318
P407
P577
2014-11-01T00:00:00Z